Local intra-arterial fibrinolysis in a treatment of the acute ischemic stroke;Celowana fibrynoliza dotetnicza w leczeniu ostrego udaru niedokrwiennego mózgu

Polish Journal of Radiology

Volumn 69, Issue 4, 2004, Pages 90-97

  Poncyljusz, Wojciech ^a   Cyryłowski, Lech ^a   Sagan, Leszek ^a   Falkowski, Aleksander ^a   Posio, Violetta ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute ischemic stroke; Local intra arterial fibrinolysis

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRIN; HEPARIN; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE DISEASE; ANAMNESIS; ARTERY DISSECTION; BLOOD CLOTTING; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN RADIOGRAPHY; BRAIN SURGERY; BRAIN TUMOR; CAROTID ARTERY BIFURCATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG WITHDRAWAL; FATALITY; FIBRINOLYSIS; FREQUENCY ANALYSIS; HEAD INJURY; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; OUTCOMES RESEARCH; REVIEW; SAFETY; SCORING SYSTEM; SEIZURE; STROKE; TREATMENT CONTRAINDICATION;

EID: 14644437013     PISSN: 1733134X     EISSN: 18990967     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Członkowska A, Ryglewicz D: Epidemiologia udarów mózgu. Terapia, 1996; 11: 9-16
2. The World Bank. World Development Report, 1993. Investing in health. Oxford University Press, Oxford, 1993
3. American Heart Association. Heart and stroke facts 1996 statistical supplement. American Heart Association, Dallas, 1995
4. Ryglewicz D, Polakowska M, Lechowicz W et al: Stroke mortality rates in Poland did not decline between 1984 and 1992. Stroke, 1997; 28 (4): 752-757
5. Bonita R, Stewart A, Beaglehole R: International trends in stroke mortality: 1970-1985. Stroke, 1990; 21: 989-992
6. Easton JD: Epidemiology of stroke recurrence. Cerebrovasc. Dis., 1997; supl.1: 2-4
7. Wolfe CD: The impact of stroke. Brit. Med. Bull., 2000; 56: 275-286
8. Furlan A, Higashida RT, Wechsler L, Gent M, and the PROACT Investigators, et al. Intraarterial prourokinase for acute ischemic stroke: The PROACT II study: A Randomized Controlled Trial. JAMA, 1999; 282: 2003-2011
9. Eckert B, Kuciński T, Neumaier-Probst E et al. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalisation success and neurological outcome. Cerebrovasc Dis, 2003; 15: 258-263
10. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue Plasminogen Activator for Acute Ischaemic Stroke. N Engl J Med, 1995; 333: 1581-1587
11. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiology evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR, 1993; 14: 3-13
12. Röther J, Schellinger P, Gass A et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6h. Stroke, 2002; 33: 2438-2445
13. Zeumer H, Freitag HJ, Zanella F et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator. Neuroradiology, 1993; 35: 159-162
14. Higashida RT, Halbach VV, Tsai FY, Dowd CF Hieshima GB: Interventional neurovascular techniques in acute thrombolytic therapy for stroke. In: Thrombolytic Therapy in Acute Ischemic Stroke 111, Yamagushi T, Mori E, Minematsu K, del Zoppo GJ, eds. Springer-Verlag: Tokyo. 1995; PP. 294-300
15. del Zoppo GJ, Higashida RT, Furian AJ, et ai. PROACT: A Phase II Randomized Trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke, 1998; 29: 4-11
16. Wallace RC, Furlan AJ, Moliterno DJ, et al. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIb/IIIa receptor inhibitor. AJNR, 1997; 18: 1257-1260
17. Abciximab in Ischemic Stroke Investigators. Abciximab in Acute Ischemic Stroke. Randomized, Double-Blind, Placebo-controlled, Dose-Escalation Study. Stroke, 2000; 31: 601-609
18. Pessin M, del Zoppo GJ, Furlan AJ: Thrombolytic treatment in acute stroke: review and update of selective topics. In: Cerebrovascular Diseases, Moskowitz MA, Caplan LR, eds. Nineteenth Princeton Stroke Conference. Butterworth-Heinemann: Boston, 1995; pp. 409-418
19. Hacke W, Kaste M, Fieschi C, Toni D, et al. Intravenous thrombolysis with recombinent tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA, 1995; 274: 1017-1025
20. del Zopo GJ, Sasahara AA: Interventional use of plasminogen activators in central nervous system diseases. Med Clin N Am, 1998; 82(3): 545-568
21. Hoffman AI, Lambiase RE, Haas RA, Rogg JM, Murphy TP: Acute vertebrobasilar occlusion: Treatment with high-dose intra-arterial urokinase. AJR, 1999; 172: 709-712
22. Cross DT, Moran CJ, Akins PT, et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR, 1996; 17: 255-262
23. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke, 1988; 19: 1216-1222
24. Schumacher M, Siekmann R, Radu W, Wakhloo AK: Local intra-arterial fibrinolytic therapy in vetebrobasilar occlusion. In: BL Bauer, M. Brock, M Klinger. Advances in Neurosurgery, 1994; 22: 30-34
25. Higashida RT, Halbach V V, Barnwell SL, Dowd CF, Hieshima GB: Thrombolytic therapy in acute stroke. J Endovascular Surg, 1994; 1: 4-15
26. Sussman BJ, Fitch TSP: Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA, 1958; 167: 1705
27. Atkin N, Nitzberg S, Dorsey J: Lysis of intracerebral thromboembolism with fibrinolysin. Report of a case. Angiology, 1964; 15: 436
28. Labauge R, Blard JM, Salvaing P et al. Traitment fibrinolytique et anticoagulant dans 37 cas d'acclusions arterielles, cervicocerebrales d'origin thrombo-embolique. In: Proceedings of the fifth international congress on thromboembolism. Bologna, 1978. Pisa, Quaderni della Coagulazione, 1980, pp. 362-364
29. Zeumer H, Hundgen R, Ferbert A, Ringelstein EB: Local intra-arterial fibrinolytic therapy in inaccessible internal carotid occlusion. Neuroradiology, 1984; 26: 315-317
30. del Zoppo GJ, Ferbert A, Otis S, Bruckman H, Hacke W, Zyroff J, Harker LA, Zeamer H: Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke, 1988; 19: 307-313
31. Mori E, Tabuchi M, Yoshida T, Yamadori A: Intracarotid urokinase with ahromboembolic occlusion of the middle cerebral artery. Stroke, 1988; 19: 802-812
32. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D: Local intraarterial fibrinolysis in the carotid territory. AJNR, 1989; 753-765
33. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C: Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology, 1993; 35: 159-162
34. Freitag HJ, Becker V, Thie A, Tilsner V, Philapitsch A, Schwarz HP: Plasminogen plus rt-PA improves intra-arterial thrombolytic therapy in acute ischemic stroke. In: Thrombolytic Therapy in Acuie ischemic Stroke ILL, Yamugushi T, Mori E, Minematsu K, del Zoppo GJ, eds. Springer-Verlag: Tokyo, 1995; pp. 271-278
35. Matsumoto K, Satoh K: Intra-arterial therapy in acute ischemic stroke. In: Thrombolytic Therapy in Acute Ischemic Stroke III, Yamagushi T, Mori E, Minematsu K, del Zoppo Gl, eds. Springer-Verlag: Tokyo, 1995; pp. 279-287
36. Goto K, Ogata N. 'Central' intra-arterial thrombolysis using a newly developed low friction guidewire/catheter system. In: Thrombolytic Therapy in Acute Ischemic Stroke III, Yamagushi T, Mori E, Minematsu K, dei Zoppo, Gl, eds. Springer-Verlag: Tokyo, 1995; pp. 301-306
37. Gönner F, Remonda L, Mattle H, Sturzenegger M, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke, 1998; 29: 1894-1900
38. Furlan AJ: Natural history of atherothromboembolic occlusion of cerebral arteries: carotid versus vertebrobasilar territories. In: Thrombolytic Therapy in Acute Ischemic Stroke, Hacke W, del Zoppo GJ, Hirschberg M, eds. New York: NY. Springer-Verlag: 1991; pp. 71-76
39. Katzan IL, Furlan AJ: Thrombolytic therapy. In: Current Review of Cerebrovascular Disease 3'd Edition, Fisher M, Bogouslavsky J, eds. Butterworth Heinemann: Boston: 1999; pp. 185-193
40. Rasmussen PA, Perl J, Barr J, Markarian GZ, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: An initial experience: J Neurosurg, 2000; 92: 771-778
41. Nistri M, Mangiafico S, Cellerini M, et al. Percutaneous transluminal cerebral angioplasty and stenting in acute vertebrobasilar ischemic stroke. Interventional Neuroradiology, 2002; 8: 135-141
42. Brandt T, von Kummer R, Muller-Kuppers M, et al. Thrombolytic therapy of acute basilar artery occlusion, variables affecting recanalization and outcome. Stroke, 1996; 27: 875-881
43. Cross DT, Moran CIJ, Akins P, et al. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR, 1997; 18: 1221-1228
44. Huemer M, Niederwieser V, Ladurner G: Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry, 1995; 58: 227-228
45. Wijdicks EF, Nichols DA, Thielen KR, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolisms: The initial Mayo Clinic experience. Mayo Clin Proc, 1997; 72: 1005-1013
46. Clark W, Barnwell S, Nesbit G, et al. Efficacy of intra-arterial thrombolysis of basilar artery stroke (abstr). J Stroke Cerebrovasc Dis, 1997; 6: 457
47. Zeumer H, Freitag HJ, Grzyska U, et al. Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Neuroradiology, 1989; 31: 336-340
48. Becker KJ, Monsein LH, Ulatowski J, et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR, 1996; 17: 255-262
49. Mitchell Pl, Gerraty RP, Dorman GA, et al. Thrombolysis in the vertebrobasilar circulation: the Australian urokinase stroke trial. Cerebrovasc Dis, 1997; 7: 94-99
50. Clark W, Wissman S, Albers G, Jhamandas J, Madden K, Hamilton S, for the ATLANTIS Investigators. Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset. JAMA, 1999; 282: 2019-2024
51. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet, 1998; 352: 1245-51
52. von Kummer R, Hacke W: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke, 1992; 23: 646-52
53. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke, 1997; 28: 2109-2118
54. Tomsick T, Brott T, Barsan W, et al. Thrombus localization with emergency CT. Am J Neuroradiol, 1992; 12: 257-263
55. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thombolysis in myocardial infarction study. Thrombolysis in myocardial infarction, phase II, pilot and clinical trial. Circulation, 1991; 83: 448-459
56. Simoons MI, Maggioni AP, Knatterud G et al. Individual risk assessment for intracranial hemorrhage during thrombolytic therapy. Lancet, 1993; 342: 1523-1528
57. Anderson JL, Karagounis L, Allen A, et al. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol, 1991; 68: 166-170
58. Gebel M, Sila CA, Sloan MA et al. Thrombolysis-related intracranial hemorrhage: A radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Stroke, 1998; 29: 563-569
59. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. AJNR, 1996; 17: 79-85
60. Lansberg MG, Tong DC, Norbash AM, Yenari MA, Moseley ME: Intra-arterial rtPA treatment of stroke assessed by diffusion- and perfusion-weighted MRI. Stroke, 1999; 30: 678-80
61. Endo S, Kuwayama N, Hirashima Y, Akai T, Nishijima M, Takaku A: Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. AJNR, 1998; 19: 1169-1175
62. Emergency Management of Stroke (EMS) Investigators: Combined intra-arterial and intravenous tPA for stroke (abstract). Stroke, 1997; 28: 273
63. Albers GW: Expanding the time window for thrombolytic therapy in acute stroke. The potential MRI trial role of acute MRI for patient selection. Stroke, 1999; 30: 2230-2237